A Phase I First-in-human, Dose-Escalation and Expansion Study to Evaluate the Safety and Tolerability of NUC-3373 in Patients with Locally Advanced, Unresectable or Metastatic Solid Malignancies.
Annals of oncology（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要